49
Participants
Start Date
May 19, 2022
Primary Completion Date
March 5, 2025
Study Completion Date
July 25, 2025
Itepekimab SAR440340
Pharmaceutical form: solution for injection in pre-filled syringe; Route of administration: subcutaneous
Investigational Site Number : 2080001, Copenhagen
Investigational Site Number : 0560001, Edegem
Investigational Site Number : 2080002, Hvidovre
Investigational Site Number : 2080003, Aalborg
Clinical Research Associates of Central PA - Dubois- Site Number : 8400011, DuBois
Penn Medicine: University of Pennsylvania Health System- Site Number : 8400016, Philadelphia
Investigational Site Number : 2760001, Großhansdorf
Investigational Site Number : 2760004, Peine
University of Miami UHealth Tower- Site Number : 8400015, Miami
Pulmonary and Medicine Associates- Site Number : 8400020, Warren
University of Kansas Medical Center- Site Number : 8400004, Kansas City
Allergy, Asthma and Clinical Research- Site Number : 8400010, Oklahoma City
University of Texas - Southwestern Medical Center- Site Number : 8400014, Dallas
University of Texas Medical Branch- Site Number : 8400001, Galveston
Investigational Site Number : 2760005, Freiburg im Breisgau
National Jewish Health Medical Center- Site Number : 8400012, Denver
UCLA Medical Center - Harbor- Site Number : 8400006, Torrance
Harvard Medical School - Massachusetts General Hospital (MGH) - Medical Practice Evaluation Center (MPEC)- Site Number : 8400007, Boston
Hospital Parana- Site Number : 0760009, Maringá
Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760003, Porto Alegre
Hospital e Maternidade Celso Pierro - PUC-Campinas- Site Number : 0760004, Campinas
Integral Pesquisa e Ensino- Site Number : 0760006, Votuporanga
Hospital Beneficência Portuguesa de São Paulo- Site Number : 0760005, São Paulo
Investigational Site Number : 5280001, Groningen
Investigational Site Number : 8260003, Wythenshawe
Investigational Site Number : 8260004, London
Investigational Site Number : 8260001, Nottingham
Investigational Site Number : 8260002, Liverpool
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY